Pulmonary hypertension in chronic obstructive pulmonary disease

Pneumonologia i Alergologia Polska

Volumn 81, Issue 4, 2013, Pages 390-398

  Weitzenblum, Emmanuel ^a   Chaouat, Ari ^b   Kessler, Romain ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Chronic respiratory failure; COPD; Out of proportion pulmonary hypertension; Pulmonary hypertension; Pulmonary vascular resistance

Indexed keywords

VASODILATOR AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLICATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HUMAN; HYPERTENSION, PULMONARY; OXYGEN THERAPY; PROGNOSIS;

CARDIAC CATHETERIZATION; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; HYPERTENSION, PULMONARY; OXYGEN INHALATION THERAPY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VASODILATOR AGENTS;

EID: 84878882563     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932-946.
2. Fishman A.P. Chronic cor pulmonale. Am. Rev. Respir. Dis. 1976; 114: 775-794.
3. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1994; 150: 833-852.
4. Weitzenblum E. Chronic cor pulmonale. Heart 2003; 89: 225-230.
5. Simonneau G., Galie N., Rubin L.J. et al. Clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2004; 43: 55-125 (12 supl. S): 5S-12S.
6. Oswald-Mammosser M., Weitzenblum E., Quoix E. et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Chest 1995; 107: 1193-1198.
7. Chaouat A., Bugnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189-194.
8. Galié N., Hoeper M.M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2009; 34: 1219-1263.
9. Badesch D.B., Champion H.C., Sanchez M.A. et al. Diagnosis and assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2009; 54 (1 supl.): S55-66.
10. Tartulier M., Bourret M., Deyrieux F. Les pressions artériel-les pulmonaires chez l'homme normal. Effets de l'âge et de l'exercice musculaire. Bull. Physiopathol. Respir. 1972; 8: 1295-1321.
11. Bishop J.M. Cardiovascular complications of chronic bronchitis and emphysema. Med. Clin. North Am. 1973; 57: 771-780.
12. Chaouat A., Naeije R., Weitzenblum E. Pulmonary hypertension in COPD. Eur. Respir. J. 2008; 32: 1371-1385.
13. Thabut G., Dauriat G., Stern J.B. et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127: 1531-1536.
14. Kessler R., Faller M., Weitzenblum E., et al. Natural history"of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 2001; 164: 219-222.
15. Naeije R., Torbicki A. More on the non invasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur. Respir. J. 1995; 8: 1445-1449.
16. Arcasoy S.M., Christie J.D., Ferrari V.A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735-740.
17. Burrows B., Kettel L.J., Niden A.H. et al. Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N. Engl. J. Med. 1972; 286: 912-918.
18. Weitzenblum E., Hirth C., Ducolone A. et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752-758.
19. Scharf S., Igbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314-322.
20. Williams B.T., Nicholl J.P. Prevalence of hypoxaemic chronic obstructive lung disease with reference to long-term oxygen therapy. Lancet 1985; 2: 369-372.
21. Boutin-Forzano S., Moreau D., Kalaboka S. et al. Reported prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation. Int. J. Tuberc. Lung Dis. 2007; 11: 695-702.
22. Wilkinson M., Langhorne C.A., Heath D. et al. A pathophysio-logical study of 10 cases of hypoxic cor pulmonale. Q. J. Med. 1988; 66: 65-85.
23. Magee F., Wright J.L., Wiggs B.R. et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 1988; 43: 183-189.
24. Hale K.A., Niewoehner D.E., Cosio M.G. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am. Rev. Respir. Dis. 1980; 122: 273-278.
25. Wright J.L., Lawson L., Pare P.D. et al. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am. Rev. Respir. Dis. 1983; 128: 702-707.
26. Santos S., Peinado V.I., Ramirez J. et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002; 19: 632-638.
27. Chabot F., Schrijen F., Poincelot F. et al. Interpretation of high wedge pressure on exercise in patients with chronic obstructive pulmonary disease. Cardiology 2001; 95: 139-145.
28. Lockhart A., Tzareva M., Nader F. et al. Elevated pulmonary artery wedge pressure at rest and during exercise in chronic bronchitis: fact or fancy. Clin. Sci. 1969; 37: 503-517.
29. Butler J., Schrijen F., Henriquez A. et al. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1988; 138: 350-354.
30. Barbera J.A., Peinado V.I., Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 892-905.
31. Fishman A.P. Hypoxia on the pulmonary circulation. How and where it acts. Circ. Res. 1976; 38: 221-231.
32. Heath D. Remodeling of the pulmonary vasculature in hypoxic lung disease. In: Peacock A.J. (ed). Pulmonary Circulation. London, Chapman & Hall; 1996: 71-79.
33. Von Euler U.S., Liljestrand G. Observation of the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand. 1946; 12: 301-320.
34. Motley H.L., Cournand A., Werko L. et al. The influence of short periods of induced acute hypoxia upon pulmonary artery pressure in man. Am. J. Physiol. 1947; 150: 315-320.
35. Fishman A.P., McClement J., Himmelstein A. et al. Effects of acute anoxia on the circulation and respiration in patients with chronic pulmonary disease studied during the steady state. J. Clin. Invest. 1952; 31: 770-781.
36. Archer S., Michelakis E. The mechanism(s) of hypoxic pulmonary vasoconstriction: potassium channels, redox 02 sensors, and controversies. News Physiol. Sci. 2002; 17: 131-137.
37. Faller D.V. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol. 1999; 26: 74-84.
38. Weitzenblum E., Schrijen F., Mohan-Kumar T. et al. Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest 1988; 94: 772-778.
39. Abraham A.S., Cole R.B., Green I.D. et al. Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studied by serial observations during recovery. Circ. Res. 1969; 24: 51-60.
40. Fletcher E.C., Levin D.C. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short and long-term oxygen. Chest 1984; 85: 6-14.
41. Penaloza D., Sime F., Banchero N. et al. Pulmonary hypertension in healthy men born and living at high altitude. Med. Thorac. 1962; 19: 449-460.
42. Wright J.L., Levy R.D., Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of patho-genesis and their implications for treatment. Thorax 2005; 60: 605-609.
43. Peinado V.I., Barbera J.A., Abate P. et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 1605-1611.
44. Joppa P., Petrasova D., Stancak B. et al. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006; 130: 326-333.
45. Eddahibi S., Chaouat A., Tu L. et al. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 475-476.
46. Hoeper M.M., Welte T. Systemic inflammation, COPD, and pulmonary hypertension. Chest 2007; 131: 634-635.
47. Eddahibi S., Chaouat A., Morrell N. et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003; 108: 1839-1844.
48. Chaouat A., Savale L., Chouaid C. et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009; 136: 678-687.
49. Weitzenblum E., Apprill A., Oswald M. et al. Pulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edema. Chest 1994; 105: 1377-1382.
50. Oswald-Mammosser M., Oswald T., Nyankiye E. et al. Non-invasive diagnosis of pulmonary hypertension in chronic obstructive pulmonary disease. Comparison of ECG, radiological measurements, echocardiography and myocardial scintigraphy. Eur. J. Respir. Dis. 1987; 71: 419-429.
51. Vonk-Noordegraaf A., Marcus J.T., Holverda S. et al. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest 2005; 127: 1898-1903.
52. Tramarin R., Torbicki A., Marchandise B. et al. Doppler echocar-diographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Eur. Heart J. 1991; 12: 103-111.
53. Fisher M.R., Criner G.J., Fishman A.P. et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur. Respir. J. 2007; 30: 914-921.
54. Torbicki A., Skwarski K., Hawrylkiewicz I. et al. Attempts at measuring pulmonary arterial pressure by means of Doppler echocardiography in patients with chronic lung disease. Eur. Respir. J. 1989; 2: 856-860.
55. Leuchte H.H., Baumgartner R.A., Nounou M.E. et al. Brain natriu-retic peptide is a prognostic parameter in chronic lung disease. Am. J. Respir. Crit. Care. Med. 2006; 173: 744-750.
56. Weitzenblum E., Ehrhart M., Rasaholinjanahary J., Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983; 44: 118-127.
57. Kessler R., Chaouat A., Schinkewitch P. et al. The obesity - hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001; 120: 369-376.
58. Humbert M., Sitbon O., Chaouat A. et al. Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care Med. 2006; 173: 1023-1030.
59. Jamieson S.W., Kapelanski D.P., Sakakibara N. et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann. Thorac. Surg. 2003; 76: 1457-1462.
60. Horsfield K., Segel N., Bishop J.M. The pulmonary circulation in chronic bronchitis at rest and during exercise breathing air and 80% oxygen. Clin. Sci. 1968; 43: 473-483.
61. Schrijen F., Uffholtz H., Polu J.M. et al. Pulmonary and systemic hemodynamic evolution in chronic bronchitis. Am. Rev. Respir. Dis. 1978; 117: 25-31.
62. Weitzenblum E., Loiseau A., Hirth C. et al. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest 1979; 75: 656-662.
63. Weitzenblum E., Sautegeau A., Ehrhart M. et al. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1984; 130: 993-998.
64. Richens J.M., Howard P. Oedema in cor pulmonale. Clin. Sci. (Lond) 1982; 62: 255-259.
65. MacNee W., Wathen C., Flenley D.C. et al. The effects of controlled oxygen therapy on ventricular function in patients with stable and decompensated cor pulmonale. Am. Rev. Respir. Dis. 1988; 137: 1289-1295.
66. Bishop J.M., Cross K.W. Physiological variables and mortality in patients with various categories of chronic respiratory disease. Bull. Eur. Physiopathol. Respir. 1984; 20: 495-500.
67. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann. Intern. Med. 1980; 93: 391-398.
68. Report of the Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-686.
69. Weitzenblum E., Sautegeau A., Ehrhart M. et al. Long term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1985; 131: 493-498.
70. Zielinski J., Tobiasz M., Hawrylkiewicz I. et al. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients. A 6-year prospective study. Chest 1998; 113: 65-70.
71. Stolz D., Rasch H., Linka A. et al. A randomised controlled trial of bosentan in severe COPD. Eur. Respir. J. 2008; 32: 619-628.
72. Vonbank K., Ziesche R., Higenbottam T.W. et al. Controlled prospective randomised trial on the effects on pulmonary haemo-dynamics of the ambulatory long-term use of nitric oxide and oxygen in patients with severe COPD. Thorax 2003; 58: 289-293.
73. Bjortuft O., Simonsen S., Geiran O.R. et al. Pulmonary haemody-namics after single-lung transplantation for end-stage pulmonary parenchymal disease. Eur. Respir. J. 1996; 9: 2007-2011.